The 2021 Medtech Contract Manufacturing Report

Download
innovation hub

Miromatrix Medical is Profiled in this Database

Updated At 02 Dec, 2019

Start Free 7 Day Trial Now
Partial description of this company
Proprietary technology for decellularizing biological organs/tissues to create an extra-cellular matrix retaining its original architecture, mechanical properties, and vascular network - suitable for scaffold transplantation or growing new functional organs/tissues by recellularization

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Miromatrix Medical plus 4858 other startups.

Start Free 7 Day Trial Now

Learn More About Miromatrix Medical

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

More

Our Clients